Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized phase 2 study of plerixafor plus G-CSF vs G-CSF alone for stem cell mobilization in multiple myeloma
2011-004783-30Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of plerixafor in multiple myeloma (MM) (2 arms), sponsored by Sanofi. Primary endpoint: Peripheral blood parameters. Started Dec 2012; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2011-004783-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004783-30.